DL [China Distance Education] 6-K: China Distance Education Holdings Limited Form 6-K Page
[China Distance Education Holdings Limited Form 6-K Page 3 4 2 China Distance Education Holdings Limited Ping Wei Chief Financial Officer 3]
MONT [MONTAGE TECHNOLOGY] 8-K: (Original Filing)
[Montage Technology Reports Fourth Quarter and Fiscal 2013 Financial Results Fourth Quarter Revenue Increases 17.9% Sequentially and 49.5% Year-Over-Year to $35.4 Million; Gross Margin was 62.4% and Operating Margin 25.1% SHANGHAI, China February 20, 2014 Fourth Quarter 2013 Highlights: Attained record revenue of $35.4 million, an increase of 17.9 percent sequentially and 49.5 percent year-over-year; Reported 62.4] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1]
MONT [MONTAGE TECHNOLOGY] 8-K: Montage Technology Reports Fourth Quarter and Fiscal 2013
[Montage Technology Reports Fourth Quarter and Fiscal 2013 Financial Results Fourth Quarter Revenue Increases 17.9% Sequentially and 49.5% Year-Over-Year to $35.4 Million; Gross Margin was 62.4% and Operating Margin 25.1% SHANGHAI, China February 20, 2014 Fourth Quarter 2013 Highlights: Attained record revenue of $35.4 million, an increase of 17.9 percent sequentially and 49.5 percent year-over-year; Reported 62.4] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)
[This Form 6-K consists of: th th An announcement regarding resolutions of the 14 CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) ANNOUNCEMENT ON THE RESOLUTIONS OF THE FOURTEENTH MEETING OF THE FIFTH SESSION OF THE BOARD OF DIRECTORS Proposal to Start the Restructuring of]
SNP [CHINA PETROLEUM & CHEMICAL] 6-K: This Form 6-K consists of: th th An
[This Form 6-K consists of: th th An announcement regarding resolutions of the 14 CHINA PETROLEUM & CHEMICAL CORPORATION (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) ANNOUNCEMENT ON THE RESOLUTIONS OF THE FOURTEENTH MEETING OF THE FIFTH SESSION OF THE BOARD OF DIRECTORS Proposal to Start the Restructuring of]
LONG [eLong] 6-K: (Original Filing)
[Quarter and Full Year Unaudited Financial Results eLong Reports Fourth Net revenues surpassed RMB1 billion and hotel room nights exceeded 25 million in 2013 LONG BEIJING, February 19, 2014 /PRNewswire/ -- eLong, Inc. (Nasdaq: Highlights – Fourth Quarter 2013 n Hotel room nights stayed in the fourth quarter n Hotel commission revenue for the fourth quarter n Net revenues for] []
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 million loss from operations XIANYANG, China, February 20, 2014 –Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 20, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth
[Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 million loss from operations XIANYANG, China, February 20, 2014 –Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 20, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
SFUN [SouFun] SC 13D/A: (Original Filing)
[SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited (Name of Issuer) Class A ordinary shares, par value HK$1.00 per share (Title of Class of Securities) 836034108** (CUSIP Number) Amit Gupta 6th Floor, Tower A 1 CyberCity, Ebene, Mauritius +230 (403) 6074 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With a copy to: Thomas J.]
SFUN [SouFun] SC 13D/A: SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited
[SCHEDULE 13D/A (Amendment No. 7) SouFun Holdings Limited (Name of Issuer) Class A ordinary shares, par value HK$1.00 per share (Title of Class of Securities) 836034108** (CUSIP Number) Amit Gupta 6th Floor, Tower A 1 CyberCity, Ebene, Mauritius +230 (403) 6074 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) With a copy to: Thomas J.]
